Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.24B |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$552M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$535M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$471M |
| 5 |
Palo Alto Networks
PANW
|
+$393M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$2.11B |
| 2 |
Apple
AAPL
|
+$2.02B |
| 3 |
Microsoft
MSFT
|
+$612M |
| 4 |
Amazon
AMZN
|
+$554M |
| 5 |
iShares MSCI EAFE Value ETF
EFV
|
+$420M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.61% |
| 2 | Consumer Discretionary | 1.65% |
| 3 | Financials | 1.07% |
| 4 | Healthcare | 1.03% |
| 5 | Communication Services | 0.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OPTU
8026
PUT
Optimum Communications Inc
OPTU
$306M
| $58.9K | ﹤0.01% |
18,000
-34,800
| -66% | -$112K |
|
8027
Spruce Power Holding Corp
SPRU
$40.8M
| $58.9K | ﹤0.01% |
10,819
+5,869
| +119% | +$39K |
|
|
CANO
8028
CALL
DELISTED
Cano Health, Inc.
CANO
| $58K | ﹤0.01% |
2,289
-602
| -21% | -$49.5K |
|
|
ASTR
8029
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
| $57.1K | ﹤0.01% |
30,869
-22,765
| -42% | -$98.8K |
|
|
CASI
8030
DELISTED
CASI Pharmaceuticals
CASI
| $56.6K | ﹤0.01% |
22,124
-6,038
| -21% | -$14.3K |
|
|
CVIIW
8031
DELISTED
Churchill Capital Corp VII Warrants
CVIIW
| $56.5K | ﹤0.01% |
183,288
-1
| -0% | – |
|
8032
CALL
BBVA Argentina
BBAR
$3.53B
| $56.4K | ﹤0.01% |
13,600
-40,700
| -75% | -$218K |
|
8033
CALL
Emergent Biosolutions
EBS
$229M
| $56.4K | ﹤0.01% |
+16,600
| New | +$92K |
|
|
LILM
8034
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
| $56.4K | ﹤0.01% |
79,063
+37,273
| +89% | +$43.5K |
|
|
AGEN
8035
CALL
Agenus
AGEN
$291M
| $55.8K | ﹤0.01% |
2,760
-245
| -8% | -$6.95K |
|
8036
The ONE Group
STKS
$56.5M
| $55.3K | ﹤0.01% |
10,050
-2,820
| -22% | -$19.2K |
|
8037
Village Farms International
VFF
$289M
| $55K | ﹤0.01% |
256,140
+49,861
| +24% | +$38.3K |
|
8038
CALL
Allogene Therapeutics
ALLO
$725M
| $54.5K | ﹤0.01% |
17,200
-5,100
| -23% | -$22.3K |
|
8039
Rockwell Medical
RMTI
$27M
| $54.3K | ﹤0.01% |
2,612
-24,619
| -90% | -$748K |
|
|
SBDS
8040
DELISTED
Solo Brands Inc
SBDS
| $54K | ﹤0.01% |
+265
| New | +$57.8K |
|
8041
Trevi Therapeutics
TRVI
$2.54B
| $53.6K | ﹤0.01% |
+24,600
| New | +$55.6K |
|
|
GBIO
8042
DELISTED
Generation Bio
GBIO
| $53.5K | ﹤0.01% |
+1,413
| New | +$66.9K |
|
|
CAN
8043
PUT
Canaan Creative
CAN
$149M
| $53.1K | ﹤0.01% |
+29,200
| New | +$68.9K |
|
8044
Inogen
INGN
$163M
| $53.1K | ﹤0.01% |
10,174
-200,919
| -95% | -$1.43M |
|
8045
Invivyd
IVVD
$198M
| $53.1K | ﹤0.01% |
31,207
-72,293
| -70% | -$115K |
|
|
8046
PUT
Allogene Therapeutics
ALLO
$725M
| $52.9K | ﹤0.01% |
+16,700
| New | +$73.2K |
|
8047
PUT
AbCellera Biologics
ABCL
$2.85B
| $52.9K | ﹤0.01% |
11,500
-400
| -3% | -$2.43K |
|
8048
PUT
Ambev
ABEV
$45.4B
| $52.6K | ﹤0.01% |
20,400
+3,900
| +24% | +$11.3K |
|
|
ALUR.WS
8049
DELISTED
Allurion Technologies Warrants
ALUR.WS
| $52.5K | ﹤0.01% |
+57,708
| New | +$47.6K |
|
8050
CALL
Lufax Holding
LU
$1.44B
| $52.4K | ﹤0.01% |
12,350
+3,900
| +46% | +$21.6K |
|
Similar funds
Jane Street's Q3 2023 Portfolio in Review
As of Q3 2023, Jane Street held 9,820 positions worth $309B, up 4.1% from $297B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Jane Street deployed $28.2B of net new capital in Q3 2023, opening 1,242 new positions and adding to 3,523 existing holdings. Its largest new stake was iShares Core MSCI Emerging Markets ETF: 11,152,855 shares worth $531M.
By sector, the portfolio is most concentrated in Technology at 2.6% of assets, down from 4% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Tesla, an estimated $2.11B trimmed.
- Jane Street's largest Q3 2023 buy was iShares Core MSCI Emerging Markets ETF: 11,152,855 shares worth $531M.
- Jane Street added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $6.24B increase.
- Jane Street's biggest Q3 2023 reduction was Tesla, cutting an estimated $2.11B.
- Jane Street fully exited iShares Silver Trust in Q3 2023, selling an estimated $130M.
- Jane Street's ten largest holdings make up 40% of its $309B portfolio in Q3 2023.
- Jane Street opened 1,242 new positions and closed 1,288 in Q3 2023.
- Jane Street's portfolio value rose 4.1% quarter-over-quarter to $309B.
Based on Jane Street's 13F filing for Q3 2023, filed 15 Nov 2023.